3rd Quarter - Report

IKON PUBLIC AFFAIRS for OCUGEN INC

Period 3rd Quarter 2022 Filed Nov 16, 2022 Signed by Corrin Merritt

Official filing
Firm
IKON PUBLIC AFFAIRS
Client
OCUGEN INC
Income
$105,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

administration policy regarding COVID19 vaccine manufacturing

LobbyistCovered position, as disclosed
CRAIG SNYDER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.